Thrombozytenanomalien bei essentieller Hypertonie^[*]

 

^* Unterstützt durch den Schweizerischen Nationalfonds Nr. 3924083 und die Schweizerische Herzstiftung

• LITERATUR

• 1 Aktories K, Jakobs K H. Ni-mediated inhibition of human-platelet adenylate cyclase by thrombin. Eur J Biochem 1984; 145: 333-8.
• 2 Allan D. Inositol lipids and membrane function in erythrocytes. Cell Calcium 1982; 03: 451-65.
• 3 Ashendel C L. The phorbolester receptor: a phospholipid regulated protein kinase. Biochem Biophys Acta 1985; 822: 219-42.
• 4 Billah M M, Lapetina E G. Formation of lysophosphatidylinositol in platelets stimulated with thrombin or ionophore. J Biol Chem 1982; 257: 12705-8.
• 5 Blaustein M P, Nelson M I. In: Carafoli E. ed. Membrane Transport of Calcium. London: Academic Press; 1982: 217-36.
• 6 Broekman M J. Phosphatidylinositol-4,5-biophosphate may represent the side of release of plasma membrane-bound Ca upon stimulation of human platelets. Biochem Biophys Res Commmun 1984; 120: 226-31.
• 7 Buckley J T, Hawthorne J N. Erythrocyte membrane polyphosphoinositide metabolism and the regulation of calcium binding. J Biol Chem 1972; 247: 7218-23.
• 8 Bygrave F L. Mitochondria and the control of intracellular calcium. Biol Rev Camb Philos Soc 1978; 53: 43-79.
• 9 Carafoli E, Crompton M. Mitochondrial Ca-transport and the intracellular Ca-homeostasis. Curr Top Membranes Transp 1978; 10: 151-216.
• 10 Carafoli E, Zurini M. The Ca²⁺-pumping ATPase of plasma membranes. Purification, reconstruction and properties. Biochim Biophys Acta 1982; 683: 279-301.
• 11 Cheung W Y. Calmodulin plays a pivotal role in cellular regulation. Science 1980; 207: 19-27.
• 12 Cockroft S. Ca²¹-dependent conversion of phosphatidylinositol to phosphatidate in neutrophils stimulated with Met-Leu-Phe or ionophore. Biochem Soc Trans 1984; 12: 966-8.
• 13 Downes C P, Michell R H. The control by Ca²¹ of the polyphosphoinositide phosphodiesterase and the Ca²¹-pump ATPase in human erythrocytes. Biochem J 1982; 202: 53-8.
• 14 Erne P, Biihler F R, Affolter H, Bürgisser E. Excitatory and inhibitory modulation of intracellular free calcium in human platelets by hormones and drugs. N Engl J Med 1984; 310: 1084-8.
• 15 Erne P, Resink T J, Bolli P, Hefti A, Ritz R, Biihler F R. Free calcium concentration in platelets closely relates to blood pressure in normal and essentially hypertensiv subjects. J Hypertension 1982; 02 (Suppl. 03) 159-61.
• 16 Erne P, Resink T J, Bürgisser E, Biihler F R. Platelets and hypertension. J Cardiovasc Pharmacol 1985; 07 (Suppl. 06) 103-8.
• 17 Friedman S M. Cellular ionic perturbations in hypertension. J Hypertension 1983; 01: 109-14.
• 18 Gerrard J M, Is’reals S J, Friesen L L. The effects of l-deoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure. Nouv Rev Fr Hematol 1985; 27: 267-73.
• 19 Greenberg-Sepersky S M, Simons E R. Cation gradient dependence of the steps in thrombin stimulation of human platelets. J Biol Chem 1984; 259: 1502-8.
• 20 Hallam T J, Sachnez A, Rink T J. Stimulus response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent Caindicator quin 2. Biochem J 1984; 218: 819-27.
• 21 Hamet P, Franks A J, Adnot S, Coquil J F. Characteristics of a new binding protein distinct from the kinase for guanosine-3’,5’-monophosphate in rat platelets. Adv Cycl Nucl Res 1980; 12: 11-23.
• 22 Haslam R J, Davidson M M L, Davies T, Lynham J A, McClenaghan M D. Regulation of blood platelet function by cyclic nucleotides. Adv Cycl Nucl Res 1978; 09: 533-52.
• 23 Isenberg G. Cardiac Purkinje fibers: (Ca²⁺) controls steady state potassium conductance. Pflüger’s Arch 1977; 371: 71-2.
• 24 Jakobs K H, Bauer S, Watanabe Y. Modulation of denylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway. Eur J Biochem 1985; 151: 425-30.
• 25 Jakobs K H, Saur W, Schultz G. Inhibition of platelet adenylate cyclase by epinephrine requires GTP. FEBS Lett 1978; 85: 167-70.
• 26 Kawaguchi T, Konishi K. Relation between phosphorylation and adenosine triphosphate-dependent Ca²¹-binding of swine and bovine erythrocytemembranes. Biochem Biophys Acta 1980; 597: 577-86.
• 27 Klee C B, Crouch T H, Richman P G. Calmodulin. Ann Rev Biochem 1980; 49: 489-515.
• 28 Kretsinger R H. Calcium-binding proteins. Int Rev Cytol 1976; 46: 323-93.
• 29 Krishnamurthi S, Westwick J, Kakkav V V. Regulation of human platelet activation-analysis of cyclooxygenase and cyclic AMP-dependent pathways. Biochem Pharmacol 1984; 33: 3025-35.
• 30 Kwan C Y. Dysfunction of calcium handling by smooth muscle in hypertension. Can J Physiol Pharmacol 1985; 63: 366-74.
• 31 Lapetina E G, Watson S P. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. Nouv Rev Fr Hematol 1985; 27: 235-8.
• 32 Le Quan K HSang, Montenay-Garestier T, Devynck M A. Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca²⁺ . Nouv Rev Fr Hematol 1985; 27: 279-83.
• 33 MacIntyre D E, Pollock W K. Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets. Biochem J 1983; 212: 433-7.
• 34 MacIntyre D E, Shaw A M, Bushfield M, MacMillan L J, McNicol A, Pllock W K. Endogenous and pharmacological mechanismus for the regulation of human platelet cytosolic free Ca²⁺ . Nouv Res Fr Hematol 1981; 27: 285-92.
• 35 Majerus P W, Wilson D B, Connely T, Bross T E, Neufield E J. Inositol cyclic phosphates are produced by cleavage of phosphatidylphosphoinositols with purified sheep seminal vesicle phospholipase C enzymes. Trends Biochem Sci 1985; 10: 168-71.
• 36 Mellwig K P, Jakobs K H. Inhibition of platelet adenylate cyclase by ADP. Thromb Res 1980; 18: 7-17.
• 37 Mills D C B. The role of cyclic nucleotides in platelets. Handbook Exp Pharmacol 1987; 58: 723-61.
• 38 Niggli V, Adunyah E S, Carafoli E. Acidic phospholipides unsaturated fatty acids, and limited proteolysis mimic the effect of calmodulin on the purified erythrocyte Ca²¹-ATPase. J Biol Chem 1981; 256: 8588-92.
• 39 O’Rourke F A, Halenda S P, Zavoico G B, Feinstein M B. Inositol 1,4,5-triphosphate releases Ca²⁺ from a Ca²⁺-transporting membrane vesicle fraction derived from human platelets. J Biol Chem 1985; 260: 956-62.
• 40 Penniston J. Substrate specificity of the erythrocyte Ca²¹-ATPase. Ann NY Acad Sci 1982; 402: 296-303.
• 41 Postnov Y V, Orlov S N. Cell membrane alterations as a source of primary hypertension. J Hypertension 1984; 02: 1-6.
• 42 Postnov Y V, Orlov S N. Ion transport across plasma membrane in primary hypertension. Physiol Rev 1985; 65: 904-45.
• 43 Rasmussen H, Goodman D B P. Relationship between calcium and cyclic nucleotides in cell activation. Physiol Rev 1977; 57: 421-509.
• 44 Rasmussen H, Kojima I, Kojima K, Zwalich W, Apfeldorf W. Ca²⁺ as intracellular messenger; sensitivity modulation, C-kinase pathway, and sustained cellular response. Adv Cycl Nucl Prot Phos 1984; 18: 159-93.
• 45 Resink T J, Bürgisser E, Bühler F R. Enhanced platelet cyclic AMP response to prostaglandin E_t in essential hypertension. Hypertension 1986; 8.
• 46 Resink T J, Stucki S, Grigorian G Y, Zschauer A, Bühler F R. Biphasic Ca²⁺ response of adenylate cyclase The role of calmodulin in its activation by Ca²⁺ ions. Eur J Biochem 1986; 154: 451-6.
• 47 Resink T J, Tkachuk V A, Bühler F R. Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Hypertension 1986; 08: 159-66.
• 48 Robinson B F. Functional differences in blood vessels determined from studies with calciumchannel blockers. Functional changes in forearm resistance vessels of men with primary hypertension. J Hypertension 1984; 02: 453-60.
• 49 Ross E M, Gilman A G. Biochemical properties of hormone-sensitive adenylate cyclase. Ann Rev Biochem 1980; 49: 533-64.
• 50 Sess W, Stifel M, Binder H, Weber P L. Activation of V_rreceptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets. Biochem J 1986; 233: 83-91.
• 51 Takai Y, Kikkawa U, Kaibuchi K, Nishizuka Y. Membrane phospholipid metabolism and signal transduction for protein phosphorylation. Adv Cycl Nucl Res 1984; 18: 119-58.
• 52 Tysnes O B, Aarbakke G M, Verhoeven A J M, Holmsen H. Thin-layer chromatography of polyphosphoinositides from platelet extracts: interference by an unknown phospholipid. Thromb Res 1985; 40: 329-38.
• 53 Vanderwel M, Lum D S, Haslam R J. Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V_rreceptors. FEBS Lett 1983; 164: 340-4.
• 54 Varsanyi M, Toile H G, Heilmayer L M G, Dawson R M C, Irvine R F. Evidence for regulation of fast skeletal muscle sarcoplasmic reticular Ca²¹-transport ATPase by phosphorylation and déphosphorylation. EMBO J 1983; 02: 1543-8.
• 55 Williams K A, Haslam R A. Effects NaCl and GTP on the inhibition of platelet adenylate cyclase by l-0-octadecyl-2-0-acetyl-glyceryl-3-phosphorylcholin (synthetic platelet-activating-factor). Biochim Biophys Acta 1984; 770: 216-23.
• 56 Zschauer A, Resink T J, Bühler F R. J Cell Biol. 1986